IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

ProQuest Associates IV LLC

Q1 2018 Holdings

Filed 2018-05-15 | 6 holdings | $87.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Urogen Pharma Ltd.(URGN)Common StockM96088105$54.5K1,096,02462.6%
Mersana Therapeutics, Inc.Common Stock59045L106$15.1K955,70917.3%
Agile Therapeutics, Inc.(AGRXUSD)Common Stock00847L100$13.0K5,062,36315.0%
Immune Design Corp.Common Stock45252L103$4.1K1,236,3944.7%
Eagle Pharmaceuticals, Inc.(EGRX)Common Stock269796108$3576,7770.4%